With this acquisition, Indegene aims to leverage technology-enabled clinical data management platform to help small, medium, and large life sciences organizations achieve cost-efficiency, quality, and acceleration in the medical outsourcing space.
Manish Gupta, CEO, Indegene, said "Accelerating time to market efficiently is essential in clinical, regulatory, and medical processes. Indegene is committed to provide this support to the life sciences industry. Wincere acquisition is a step further in this direction."
"Indegene's core capabilities around Analytics, Technology, Operations, and Medical (ATOM) will be leveraged to gain faster access to cleaner data leading to insightful analytics. Integration of Wincere's expertise and solutions will further strengthen our medical, scientific, and clinical capabilities in signal detection, data visualization, and risk-based monitoring," added Dr. Rajesh Nair, president, Indegene Inc.
Sandeep Bhat, CEO, Wincere Inc., mirrored the thought saying "Wincere offers innovative solutions to the life sciences industry to remain ahead-of-the-curve. Together with Indegene's cutting-edge technology and highly experienced global team, we will create an exceptional partnership in the area of medical outsourcing."
Himanshu Kansara, president, Wincere Inc., explained that "With Indegene's proven experience in providing medical and commercial solutions, and deep technology and analytics capabilities, we are excited to bring new technology-based platforms to this space."
Wincere provides smarter clinical research services across all clinical trial phases by using its patent-pending technology to support clinical trial startup, conduct, and submission activities.
Indegene enables global healthcare organizations address complex challenges by seamlessly integrating analytics, technology, operations, and medical expertise and drive better health and business outcomes.
Indegene acquires california, based clinical data management provider, wincere to strengthen medical outsourcing market